The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma

Clinical trial NCT06807112 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06807112
Sponsor: Charles University, Czech Republic
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Pancreatic Adenocarcinoma Pancreatic Cancer

Start date: 2025-02-09
Primary completion: 2026-06-30
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.